Literature DB >> 16086610

Clinical utility of magnetic resonance imaging radiographs for suspected organic syndromes in adult psychiatry.

Stephen M Erhart1, Alexander S Young, Stephen R Marder, Jim Mintz.   

Abstract

OBJECTIVE: In psychiatric practice, adult patients are most commonly referred for magnetic resonance imaging (MRI) to screen for suspected organic medical diseases of the central nervous system that can mimic psychiatric syndromes. We identified the most common signs and symptoms prompting MRIs to establish the predictive value of these signs and symptoms for clinically pertinent organic syndromes.
METHOD: This study was a retrospective chart review of psychiatric patients at the Veterans Affairs Greater Los Angeles Health Care Center (Los Angeles, Calif.) who were referred for MRI of the brain between 1996 and 2002. Patients referred for evaluation of dementia were excluded. The specific indications leading clinicians to obtain MRI were identified and grouped. In order to offset the uncertain significance of many MRI findings, for this study, the predictive value of each indication was calculated based on the percentage of patients in whom clinical management changed in response to MRI findings rather than on the percentage with any abnormal MRI results.
RESULTS: Of 253 patients who had MRIs, 38 (15%) incurred some degree of treatment modification as a result of MRI findings, including 6 patients in whom MRI identified a medical condition that became the focus of treatment. Six indications appeared most likely to prompt clinicians to obtain MRIs. Because pertinent results were associated with each of these indications, statistical evaluation did not reveal significant differences in their predictive values (chi(2) = 4.32, df = 5, p = .505).
CONCLUSIONS: Unlike prior studies showing no value to screening radioimaging, this study shows MRI can be a useful screening test among patients suspected of having organic psychiatric disorders and that the common indications for MRI employed at one institution were predictive.

Entities:  

Mesh:

Year:  2005        PMID: 16086610     DOI: 10.4088/jcp.v66n0802

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  7 in total

1.  Frontotemporal Dementia and Psychiatric Illness: Emerging Clinical and Biological Links in Gene Carriers.

Authors:  Nikolas R Block; Sharon J Sha; Anna M Karydas; Jamie C Fong; Mary G De May; Bruce L Miller; Howard J Rosen
Journal:  Am J Geriatr Psychiatry       Date:  2015-06-21       Impact factor: 4.105

2.  The value of thoracic computed tomography scans in clinical diagnosis: a prospective study.

Authors:  Mark O Turner; John R Mayo; Nestor L Müller; Michael Schulzer; J Mark FitzGerald
Journal:  Can Respir J       Date:  2006-09       Impact factor: 2.409

3.  Clinical translation of neuroimaging research in mood disorders.

Authors:  Jakub Z Konarski; Roger S McIntyre; Joanna K Soczynska; Alexandra Bottas; Sidney H Kennedy
Journal:  Psychiatry (Edgmont)       Date:  2006-02

Review 4.  Neuroplasticity of Acupuncture for Stroke: An Evidence-Based Review of MRI.

Authors:  Jinhuan Zhang; Chunjian Lu; Xiaoxiong Wu; Dehui Nie; Haibo Yu
Journal:  Neural Plast       Date:  2021-08-19       Impact factor: 3.599

Review 5.  Deconstructing psychosis with human brain imaging.

Authors:  Raquel E Gur; Matcheri S Keshavan; Stephen M Lawrie
Journal:  Schizophr Bull       Date:  2007-06-04       Impact factor: 9.306

6.  Neuroimaging Education in Psychiatry Residency Training: Needs Assessment.

Authors:  Michel Medina; Daniel Lee; David Martinez Garza; Eric L Goldwaser; Thanh Thuy Truong; Abena Apraku; Jessica Cosgrove; Joseph J Cooper
Journal:  Acad Psychiatry       Date:  2019-12-18

7.  A retrospective chart review of clinical characteristics and magnetic resonance imaging findings of patients from a psychiatric facility in KwaZulu-Natal province, South Africa.

Authors:  Vidette M Juby; Saeeda Paruk
Journal:  S Afr J Psychiatr       Date:  2019-11-27       Impact factor: 1.550

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.